14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Jan 10, 2020 $0.0200 $0.0290 $0.0200 $0.0290 2 024
Jan 09, 2020 $0.0201 $0.0288 $0.0201 $0.0288 2 485
Jan 08, 2020 $0.0300 $0.0325 $0.0187 $0.0314 506 459
Jan 07, 2020 $0.0250 $0.0344 $0.0250 $0.0330 24 677
Jan 06, 2020 $0.0358 $0.0360 $0.0251 $0.0360 44 366
Jan 03, 2020 $0.0310 $0.0350 $0.0310 $0.0340 7 022
Jan 02, 2020 $0.0248 $0.0360 $0.0248 $0.0323 15 313
Dec 31, 2019 $0.0266 $0.0360 $0.0250 $0.0342 102 076
Dec 30, 2019 $0.0260 $0.0314 $0.0250 $0.0314 174 600
Dec 27, 2019 $0.0260 $0.0315 $0.0260 $0.0315 50 725
Dec 26, 2019 $0.0300 $0.0323 $0.0250 $0.0290 651 686
Dec 24, 2019 $0.0301 $0.0323 $0.0300 $0.0323 47 371
Dec 23, 2019 $0.0285 $0.0323 $0.0285 $0.0323 70 482
Dec 20, 2019 $0.0310 $0.0360 $0.0301 $0.0327 24 583
Dec 19, 2019 $0.0301 $0.0380 $0.0300 $0.0360 43 399
Dec 18, 2019 $0.0285 $0.0400 $0.0285 $0.0398 14 614
Dec 17, 2019 $0.0185 $0.0419 $0.0185 $0.0400 70 733
Dec 16, 2019 $0.0285 $0.0379 $0.0285 $0.0370 42 639
Dec 13, 2019 $0.0171 $0.0389 $0.0171 $0.0350 420 930
Dec 12, 2019 $0.0340 $0.0400 $0.0335 $0.0400 11 947
Dec 11, 2019 $0.0341 $0.0390 $0.0340 $0.0365 71 683
Dec 10, 2019 $0.0371 $0.0390 $0.0341 $0.0390 20 261
Dec 09, 2019 $0.0301 $0.0424 $0.0301 $0.0420 30 380
Dec 06, 2019 $0.0344 $0.0419 $0.0340 $0.0419 51 199
Dec 05, 2019 $0.0342 $0.0430 $0.0335 $0.0428 171 077
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT